The short answer

Women deserve weight-loss care that begins with a medical baseline and continues through nutrition, medication monitoring, strength, body composition, appearance, maintenance and women’s wellness—not a vial delivered without context.

A prescription is a tool. It is not the program.

GLP-1–based medicines have changed obesity care and can be very effective for eligible patients. But the medication cannot take a complete history, identify a contraindication, notice dehydration, help you preserve muscle or decide whether a new symptom needs evaluation.

That is why our approach begins with the patient, not the product. We ask what you have tried, what changed, what you eat, how you sleep, which medications you take, whether pregnancy is possible and what outcome would genuinely improve your life.

Why we establish a baseline before treatment

I have met patients who previously received a GLP-1 prescription without any meaningful baseline laboratory work. That concerns me—not because every person needs every test, but because responsible care requires enough information to understand the starting point and identify risks that may affect treatment.

At Identity Aesthetics, baseline chemistry is part of our weight-management protocol. The exact evaluation is individualized and may include metabolic, kidney, liver, glucose-related, thyroid or other measures based on history and clinician judgment. We also review the current medication label, personal and family history, symptoms, pregnancy plans and possible drug interactions.

A thyroid clarification: universal thyroid blood testing is not a blanket label requirement for every GLP-1 patient. Current labels emphasize contraindications involving personal or family history of medullary thyroid carcinoma and MEN 2, while noting that routine calcitonin or thyroid-ultrasound monitoring has uncertain value. Good screening combines history, examination, indicated testing and follow-up.

Nutrition can determine whether the plan feels sustainable

At Identity Aesthetics, nutrition is treated as clinical support—not a handout at the end of a visit. Sarah’s review brings the perspective of an advanced practice nurse with a bachelor’s degree in nutrition. Appetite suppression can make it easier to eat less, but eating less is not automatically the same as eating well.

There is no universal food that “cancels” GLP-1 therapy. However, large or high-fat meals, concentrated sweets, highly processed foods and alcohol may worsen nausea, fullness or other gastrointestinal symptoms in some patients—or simply make progress harder to sustain. Guidance should adapt to your symptoms and culture, schedule, preferences and medical needs.

  • Prioritize adequate protein and resistance activity to support lean tissue.
  • Use hydration and fiber thoughtfully, especially when constipation or reduced intake appears.
  • Adjust meal size, pace and timing as fullness signals change.
  • Report persistent vomiting, severe abdominal pain or inability to stay hydrated promptly.
  • Build a realistic maintenance pattern before reaching the goal weight.

We anticipate more than the number on the scale

Significant weight reduction can improve health and confidence, but it may also reveal concerns that deserve a plan. Lean tissue can be lost along with fat. Skin laxity may become more visible. Facial fat compartments can change after substantial or rapid weight loss from any cause.

“Ozempic face” is an informal social-media term, not a medical syndrome. If facial or body changes bother you, an anatomy-based evaluation may include time, nutrition, skin care, ultrasound-based tightening, laser rejuvenation, neuromodulators or dermal fillers. Not every option belongs in every plan, and the best timing differs from patient to patient.

For many women, improved confidence also creates space to discuss concerns that were previously easier to ignore—vaginal dryness, discomfort or urinary leakage, for example. Those symptoms are common, but they are not all the same diagnosis. We can provide a private evaluation, explain appropriate options and make referrals when the right care sits outside our scope.

Where peptides fit

Additional peptide-based therapies are not automatically added to “boost” a GLP-1. We consider them only for a separately defined clinical need, when lawful, appropriately sourced and supported by credible evidence. Patients deserve to know whether a product is FDA-approved for the proposed use, compounded or investigational—and what that distinction means.

A Motivational Starting Point

See Your Future Self.

Use the Ageless AI experience to visualize the confidence you are working toward, then bring that inspiration to a real consultation where health, anatomy and achievable goals guide the plan.

This third-party AI visualization is illustrative, not a clinical before-and-after or prediction of weight, body-composition, facial or medication outcomes. Results vary; no outcome is guaranteed. Review the third party’s displayed privacy information before uploading a photograph or personal information.

Five questions every patient should ask

  1. What makes me a candidate for this medication or program?
  2. What baseline evaluation and follow-up will you use for me—and why?
  3. Who do I contact if side effects appear?
  4. How will we support nutrition, strength and maintenance?
  5. Is every medication FDA-approved for this use, compounded or investigational, and where is it sourced?
Sarah Walker, APRN, FNP-C

Reviewed by Sarah Walker, APRN, FNP-C

Advanced Provider and Nutritionist
With more than 20 years in healthcare, Sarah combines advanced-practice nursing, a Master of Science in Nursing and a Bachelor of Science in Nutrition with an emphasis in sports nutrition and disease prevention and management.

Sources & further reading

  1. FDA: Current Wegovy prescribing information
  2. FDA: Current Zepbound prescribing information
  3. 2025 clinical practice guideline update on obesity pharmacotherapy
  4. Study of midfacial volume changes associated with GLP-1 treatment

Educational content is not medical advice and does not establish a clinician-patient relationship. Treatment eligibility, testing, medication selection and results vary.